BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol 2015; 7(3): 425-442 [PMID: 25848468 DOI: 10.4254/wjh.v7.i3.425]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/425.htm
Number Citing Articles
1
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver CirrhosisInternational Journal of Molecular Sciences 2021; 22(13): 6921 doi: 10.3390/ijms22136921
2
Bahaa Eldeen Senousy Ismail, John M. Rivas, Xaralambos B. Zervos. Surgical Procedures on the Cirrhotic Patient2017; : 1 doi: 10.1007/978-3-319-52396-5_1
3
Suraphan Panyod, Wei-Kai Wu, Kuan-Hung Lu, Chun-Ting Liu, Yung-Lin Chu, Chi-Tang Ho, Wen-Luan Wendy Hsiao, Yi-Syuan Lai, Wei-Cheng Chen, Yu-En Lin, Shi-Hang Lin, Ming-Shiang Wu, Lee-Yan Sheen. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis MiceJournal of Agricultural and Food Chemistry 2020; 68(10): 3088 doi: 10.1021/acs.jafc.9b07555
4
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
5
Haiyan Shi, Longxian Lv, Hongcui Cao, Haifeng Lu, Ning Zhou, Jiezuan Yang, Haiyin Jiang, Huihui Dong, Xinjun Hu, Wei Yu, Xiawei Jiang, Beiwen Zheng, Lanjuan Li. Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in ratsScientific Reports 2017; 7(1) doi: 10.1038/srep40516
6
Rida Abid Hasan, Andrew Y. Koh, Ayesha Zia. The gut microbiome and thromboembolismThrombosis Research 2020; 189: 77 doi: 10.1016/j.thromres.2020.03.003
7
Chien-Fu Hsu, Ming-Wei Lin, Chia-Chang Huang, Tzu-Hao Li, Chih-Wei Liu, Shiang-Fen Huang, Ying-Ying Yang, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin. Roles and mechanisms of circulating CEACAM1 in the cirrhosis-related intestinal hyperpermeability: in vitro approachJournal of the Chinese Medical Association 2021; 84(9): 851 doi: 10.1097/JCMA.0000000000000582
8
Panomwat Amornphimoltham, Peter S. T. Yuen, Robert A. Star, Asada Leelahavanichkul. Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial SepsisDigestive Diseases and Sciences 2019; 64(9): 2416 doi: 10.1007/s10620-019-05581-y
9
H. Fukui. Liver Pathophysiology2017; : 341 doi: 10.1016/B978-0-12-804274-8.00027-8
10
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidenceTranslational Research 2016; 167(1): 116 doi: 10.1016/j.trsl.2015.08.002
11
Jing Yuan, Chen Chen, Jinghua Cui, Jing Lu, Chao Yan, Xiao Wei, Xiangna Zhao, NanNan Li, Shaoli Li, Guanhua Xue, Weiwei Cheng, Boxing Li, Huan Li, Weishi Lin, Changyu Tian, Jiangtao Zhao, Juqiang Han, Daizhi An, Qiong Zhang, Hong Wei, Minghua Zheng, Xuejun Ma, Wei Li, Xiao Chen, Zheng Zhang, Hui Zeng, Sun Ying, JianXin Wu, Ruifu Yang, Di Liu. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniaeCell Metabolism 2019; 30(4): 675 doi: 10.1016/j.cmet.2019.08.018
12
Ariel Aday, Jacqueline G. O’Leary. Acute on Chronic Liver FailureClinics in Liver Disease 2020; 24(3): 521 doi: 10.1016/j.cld.2020.04.004
13
Marek Droździk, Stefan Oswald, Agnieszka Droździk. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal TractInternational Journal of Molecular Sciences 2020; 21(16): 5737 doi: 10.3390/ijms21165737
14
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk managementTerapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
15
Irina Gîrleanu, Anca Trifan, Carol Stanciu, Cătălin Sfarti. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big pictureWorld Journal of Gastroenterology 2018; 24(39): 4419-4427 doi: 10.3748/wjg.v24.i39.4419
16
David Uihwan Lee, Greg Hongyuan Fan, Ryan Richard Ahern, Raffi Karagozian. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital dataEuropean Journal of Gastroenterology & Hepatology 2021; 32(2): 269 doi: 10.1097/MEG.0000000000001991
17
Seiichi Ishida. Organ-on-a-chip2020; : 181 doi: 10.1016/B978-0-12-817202-5.00005-X
18
Hiroshi Fukui. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies UpdateGut and Liver 2021; 15(5): 666 doi: 10.5009/gnl20032
19
Yasushi Okura, Tadashi Namisaki, Shinya Sato, Kei Moriya, Takemi Akahane, Mitsuteru Kitade, Hideto Kawaratani, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Naotaka Shimozato, Kenichiro Seki, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Yukihisa Fujinaga, Takuya Kubo, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Koh Kitagawa, Tsuyoshi Mashitani, Hiroyuki Ogawa, Koji Ishida, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisHepatology Research 2019; 49(2): 232 doi: 10.1111/hepr.13249
20
Hui Huan, Tao Ren, Li Xu, Hong Hu, Chao Liu. Compositional distinction of gut microbiota between Han Chinese and Tibetan populations with liver cirrhosisPeerJ 2021; 9: e12142 doi: 10.7717/peerj.12142
21
Daniela Machado, Diana Almeida, Catarina Leal Seabra, José Carlos Andrade, Ana Maria Gomes, Ana Cristina Freitas. Functional BionanomaterialsNanotechnology in the Life Sciences 2020; : 389 doi: 10.1007/978-3-030-41464-1_17
22
Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa, Masanori Furukawa, Shinya Sato, Hideto Kawaratani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversityWorld Journal of Gastroenterology 2017; 23(47): 8355-8366 doi: 10.3748/wjg.v23.i47.8355
23
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and managementNature Reviews Gastroenterology & Hepatology 2016; 13(3): 131 doi: 10.1038/nrgastro.2015.219
24
Henning Grønbæk, Sidsel Rødgaard-Hansen, Niels Kristian Aagaard, Vicente Arroyo, Søren K. Moestrup, Elisabet Garcia, Elsa Solà, Marco Domenicali, Salvatore Piano, Hendrik Vilstrup, Holger Jon Møller. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)Journal of Hepatology 2016; 64(4): 813 doi: 10.1016/j.jhep.2015.11.021
25
Masanori Furukawa, Kei Moriya, Jiro Nakayama, Takako Inoue, Rie Momoda, Hideto Kawaratani, Tadashi Namisaki, Shinya Sato, Akitoshi Douhara, Kosuke Kaji, Mitsuteru Kitade, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Yasuhito Tanaka, Hitoshi Yoshiji. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitisHepatology Research 2020; 50(7): 840 doi: 10.1111/hepr.13509
26
Akika Fukawa, Shunsuke Baba, Kaori Iwasawa, Makoto Yamaguchi, Akira Hosono. Dietary α-Lactalbumin protects against thioacetamide-induced liver cirrhosis by maintaining gut-liver axis function in ratsBioscience, Biotechnology, and Biochemistry 2020; 84(1): 171 doi: 10.1080/09168451.2019.1660613
27
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASHInternational Journal of Molecular Sciences 2016; 17(9): 1575 doi: 10.3390/ijms17091575
28
Angela Horvath, Bettina Leber, Nicole Feldbacher, Markus Steinwender, Irina Komarova, Florian Rainer, Andreas Blesl, Vanessa Stadlbauer. The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59550-x
29
Fernando Magdaleno, Maximilian Joseph Brol, Robert Schierwagen, Frank Erhard Uschner, Michael Zwick, Jonel Trebicka. The Human Gut-Liver-Axis in Health and Disease2019; : 235 doi: 10.1007/978-3-319-98890-0_14
30
Tzu-Hao Li, Chih-Wei Liu, Chia-Chang Huang, Yu-Lien Tsai, Shiang-Fen Huang, Ying-Ying Yang, Chang-Youh Tsai, Ming-Chih Hou, Han-Chieh Lin. Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort StudyJournal of Clinical Medicine 2021; 10(11): 2244 doi: 10.3390/jcm10112244
31
Jag Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela Starke-Reed, Van S. Hubbard. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision MedicineClinical Pharmacology in Drug Development 2017; 6(2): 176 doi: 10.1002/cpdd.310
32
Joong-won Jeon, Nakwon Choi, Seung Hwan Lee, Jong Hwan Sung. Three-tissue microphysiological system for studying inflammatory responses in gut-liver AxisBiomedical Microdevices 2020; 22(4) doi: 10.1007/s10544-020-00519-y
33
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Aliya Alieva, Ekaterina Kashuh, Ekaterina Tsvetaeva, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosisWorld Journal of Hepatology 2021; 13(5): 557-570 doi: 10.4254/wjh.v13.i5.557
34
Junwei Xiang, Zhengyan Zhang, Hongyi Xie, Chengcheng Zhang, Yan Bai, Hua Cao, Qishi Che, Jiao Guo, Zhengquan Su. Effect of different bile acids on the intestine through enterohepatic circulation based on FXRGut Microbes 2021; 13(1): 1949095 doi: 10.1080/19490976.2021.1949095
35
K V Zhdanov, S S Karyakin, K V Kozlov, D A Gusev, V S Sukachev, A V Saulevich, M V Yaremenko, S N Kizhlo, D M Shahmanov, D Yu Lobzin, M V Kurtukov, M A Dzheriev. Chronic hepatitis С and non-alcoholic fatty liver disease. Main aspects of pathogenesisBulletin of the Russian Military Medical Academy 2018; 20(1): 216 doi: 10.17816/brmma12326
36
Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and PrognosisJournal of Clinical and Experimental Hepatology 2020; 10(4): 339 doi: 10.1016/j.jceh.2020.04.012
37
UEG Week 2016 Poster PresentationsUnited European Gastroenterology Journal 2016; 4(5_suppl): A157 doi: 10.1177/2050640616663689
38
Claudia C. Alves, Dan L. Waitzberg, Laila S. de Andrade, Laís dos Santos Aguiar, Milene B. Reis, Camila C. Guanabara, Odair A. Júnior, Daniel A. Ribeiro, Priscila Sala. Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat LiverFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02010
39
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
40
Melisa Dirchwolf, Andrés Eduardo Ruf. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosisWorld Journal of Hepatology 2015; 7(16): 1974-1981 doi: 10.4254/wjh.v7.i16.1974
41
Young-Kook Kim, Juhyun Song. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and InflammationJournal of Clinical Medicine 2021; 10(17): 3819 doi: 10.3390/jcm10173819
42
Hiroshi Fukui. Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?World Journal of Gastroenterology 2015; 21(41): 11584-11596 doi: 10.3748/wjg.v21.i41.11584
43
Shiv Kumar Sarin, Ashok Choudhury. Acute-on-chronic Liver FailureCurrent Gastroenterology Reports 2016; 18(12) doi: 10.1007/s11894-016-0535-8
44
Andrea Mancini, Francesca Campagna, Piero Amodio, Kieran M. Tuohy. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathyFood & Function 2018; 9(3): 1373 doi: 10.1039/C7FO01528C
45
Seong-Yeop Jeong, Suna Kang, Cao Shi Hua, Zhang Ting, Sunmin Park. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient ratsGenes & Nutrition 2017; 12(1) doi: 10.1186/s12263-017-0585-z
46
Linhao Zhang, Yang Tai, Shihang Tang, Chong Zhao, Huan Tong, Jinhang Gao, Chengwei Tang. Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic RatsDigestive Diseases and Sciences 2021; 66(1): 131 doi: 10.1007/s10620-020-06178-6
47
Juliette Mouries, Paola Brescia, Alessandra Silvestri, Ilaria Spadoni, Marcel Sorribas, Reiner Wiest, Erika Mileti, Marianna Galbiati, Pietro Invernizzi, Luciano Adorini, Giuseppe Penna, Maria Rescigno. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis developmentJournal of Hepatology 2019; 71(6): 1216 doi: 10.1016/j.jhep.2019.08.005
48
Steven L. Flamm, Kevin D. Mullen, Zeev Heimanson, Arun J. Sanyal. Rifaximin has the potential to prevent complications of cirrhosisTherapeutic Advances in Gastroenterology 2018; 11: 175628481880030 doi: 10.1177/1756284818800307
49
Jiadi Wu, Daqiang Wu, Kelong Ma, Tianming Wang, Gaoxiang Shi, Jing Shao, Changzhong Wang, Guiming Yan. Paeonol ameliorates murine alcohol liver disease via mycobiota‐mediated Dectin‐1/IL‐1β signaling pathwayJournal of Leukocyte Biology 2020; 108(1): 199 doi: 10.1002/JLB.3MA0120-325RR
50
Roberto Carnevale, Valeria Raparelli, Cristina Nocella, Simona Bartimoccia, Marta Novo, Anna Severino, Elena De Falco, Vittoria Cammisotto, Chiara Pasquale, Clara Crescioli, Antonio Sili Scavalli, Oliviero Riggio, Stefania Basili, Francesco Violi. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosisJournal of Hepatology 2017; 67(5): 950 doi: 10.1016/j.jhep.2017.07.002
51
Rebeca Pérez-Cabeza De Vaca, Balasubramaniyan Vairappan, Tomás Cortés Espinoza, Juan Antonio Suárez Cuenca, Cuauhtemoc Licona Cassani, Brenda Maldonado Arriaga, Chrisitan Navarro Gerrard, Diana Selene Morgan Penagos, Paul Mondragón Terán, Victoria Chagoya De Sanchez. Advances in Hepatology2021;  doi: 10.5772/intechopen.96910
52
Francesca Romana Ponziani, Maria Assunta Zocco, Lucia Cerrito, Antonio Gasbarrini, Maurizio Pompili. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implicationsExpert Review of Gastroenterology & Hepatology 2018; 12(7): 641 doi: 10.1080/17474124.2018.1481747
53
Laurent Grosse, Dmitry V. Bulavin. LSEC model of agingAging 2020; 12(11): 11152 doi: 10.18632/aging.103492
54
Tao Zhang, Kewei Sun, Ya Wang, Lei Huang, Ren Lang, Wei Jiang. Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failureEuropean Journal of Gastroenterology & Hepatology 2018; 30(2): 130 doi: 10.1097/MEG.0000000000001026
55
Valeria Raparelli, Stefania Basili, Roberto Carnevale, Laura Napoleone, Maria Del Ben, Cristina Nocella, Simona Bartimoccia, Cristina Lucidi, Giovanni Talerico, Oliviero Riggio, Francesco Violi. Low‐grade endotoxemia and platelet activation in cirrhosisHepatology 2017; 65(2): 571 doi: 10.1002/hep.28853
56
Mohammad Mehdi Ommati, Omid Farshad, Khadijeh Mousavi, Akram Jamshidzadeh, Mohammadreza Azmoon, Sirus Heidari, Negar Azarpira, Hossein Niknahad, Reza Heidari. Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic ratsPharmaNutrition 2020; 12: 100179 doi: 10.1016/j.phanu.2020.100179
57
Priyankar Dey. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease modelsLife Sciences 2020; 258: 118172 doi: 10.1016/j.lfs.2020.118172
58
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
59
Eric K. Kwong, Huiping Zhou. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseasesLiver Research 2019; 3(1): 19 doi: 10.1016/j.livres.2019.02.003
60
Xin Chi, Calvin Q. Pan, Shunai Liu, Danying Cheng, Ziwen Cao, Huichun Xing, Alessandro Granito. Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver DiseaseCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/6629196
61
Juan Lu, Chun-lei Chen, Jian-di Jin, Jun Chen, Cheng-bo Yu. Continuous elevation of procalcitonin in cirrhosis combined with hepatic carcinoma: a case reportBMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-020-05684-2
62
Kelly A. Fader, Rance Nault, Dustin A. Ammendolia, Jack R. Harkema, Kurt J. Williams, Robert B. Crawford, Norbert E. Kaminski, Dave Potter, Bonnie Sharratt, Timothy R. Zacharewski. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 MiceToxicological Sciences 2015; 148(2): 567 doi: 10.1093/toxsci/kfv206
63
Beatriz Garcia Mendes, Bernd Schnabl. From intestinal dysbiosis to alcohol-associated liver diseaseClinical and Molecular Hepatology 2020; 26(4): 595 doi: 10.3350/cmh.2020.0086
64
Fatuma Meyer, Karen Bannert, Mats Wiese, Susanne Esau, Lea F. Sautter, Luise Ehlers, Ali A. Aghdassi, Cornelia C. Metges, Leif-A. Garbe, Robert Jaster, Markus M. Lerch, Georg Lamprecht, Luzia Valentini. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver CirrhosisInternational Journal of Molecular Sciences 2020; 21(15): 5357 doi: 10.3390/ijms21155357
65
Yong-Tao Li, Jian-Rong Huang, Mei-Lian Peng. Current Status and Prospects of Spontaneous Peritonitis in Patients with CirrhosisBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3743962
66
Thenappan Thenappan, Alexander Khoruts, Yingjie Chen, E. Kenneth Weir. Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?American Journal of Physiology-Heart and Circulatory Physiology 2019; 317(5): H1093 doi: 10.1152/ajpheart.00416.2019
67
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver DiseaseJournal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
68
Fanny Giron, Eamonn M M Quigley. Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical PerspectiveJournal of Neurogastroenterology and Motility 2018; 24(3): 355 doi: 10.5056/jnm18004
69
Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, Yukihisa Fujinaga, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Daisuke Kaya, Yuki Tsuji, Yasuhiko Sawada, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic PatientsAntibiotics 2020; 9(4): 145 doi: 10.3390/antibiotics9040145
70
Nasrin Mehranfard, Azadeh Yazdi, Asiye Rafiee Sardooi, Zeinab Shakerin, Maedeh Ghasemi. Honey protects against chronic unpredictable mild stress induced- intestinal barrier disintegration and hepatic inflammationMolecular Biology Reports 2020; 47(11): 8475 doi: 10.1007/s11033-020-05888-4
71
Jennifer L Peng, Witina Techasatian, Takashi Hato, Suthat Liangpunsakul. Role of endotoxemia in causing renal dysfunction in cirrhosisJournal of Investigative Medicine 2020; 68(1): 26 doi: 10.1136/jim-2019-001056
72
A. Horvath, B. Leber, B. Schmerboeck, M. Tawdrous, G. Zettel, A. Hartl, T. Madl, S. Stryeck, D. Fuchs, S. Lemesch, P. Douschan, E. Krones, W. Spindelboeck, F. Durchschein, F. Rainer, G. Zollner, R. E. Stauber, P. Fickert, P. Stiegler, V. Stadlbauer. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosisAlimentary Pharmacology & Therapeutics 2016; 44(9): 926 doi: 10.1111/apt.13788
73
Chunwei Cheng, Jun Tan, Wei Qian, Lei Zhang, Xiaohua Hou. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunctionLife Sciences 2018; 209: 157 doi: 10.1016/j.lfs.2018.08.017
74
Na Young Lee, Ki Tae Suk. The Role of the Gut Microbiome in Liver Cirrhosis TreatmentInternational Journal of Molecular Sciences 2020; 22(1): 199 doi: 10.3390/ijms22010199
75
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. Cirrhotic CardiomyopathyCurrent Gastroenterology Reports 2020; 22(9) doi: 10.1007/s11894-020-00783-1
76
Yoo Li Lim, Moon Young Kim, Yoon Ok Jang, Soon Koo Baik, Sang Ok Kwon. Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot StudyGut and Liver 2017; 11(5): 702 doi: 10.5009/gnl16478
77
Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Diet-Regulating Microbiota and Host Immune System in Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(12): 6326 doi: 10.3390/ijms22126326
78
Edford Sinkala, Kanekwa Zyambo, Ellen Besa, Patrick Kaonga, Bright Nsokolo, Violet Kayamba, Michael Vinikoor, Rabison Zulu, Martin Bwalya, Graham R. Foster, Paul Kelly. Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control TrialThe American Journal of Tropical Medicine and Hygiene 2018; 98(4): 1152 doi: 10.4269/ajtmh.17-0637
79
Jian-Xin Song, Lin Zhu, Chuan-Long Zhu, Jin-Hua Hu, Zi-Jian Sun, Xiang Xu, Min-You Xin, Qiong-Fang Zhang, Da-Zhi Zhang, Jia Shang, Jia-Quan Huang, Dong Xu. Acute Exacerbation of Chronic Hepatitis B2019; : 91 doi: 10.1007/978-94-024-1603-9_2
80
Atsushi Hosui, Takafumi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu. Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic AscitesJournal of Clinical Medicine 2021; 10(2): 294 doi: 10.3390/jcm10020294
81
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCCInternational Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
82
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver diseaseThe Journal of Nutritional Biochemistry 2018; 60: 1 doi: 10.1016/j.jnutbio.2018.03.006
83
Chun-Ze Zhou, Rui-Feng Wang, Wei-Fu Lv, Yu-Qin Fu, De-Lei Cheng, Yi-Jiang Zhu, Chang-Long Hou, Xian-Jun Ye. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndromeWorld Journal of Gastroenterology 2020; 26(24): 3472-3483 doi: 10.3748/wjg.v26.i24.3472
84
D. A. Kashtanova, O. N. Tkacheva. The phenomenon of intestinal permeability and its association with cardiovascular disease. Current statusCardiovascular Therapy and Prevention 2020; 19(3): 2474 doi: 10.15829/1728-8800-2020-2474
85
Piotr Wosiewicz, Michał Żorniak, Marek Hartleb, Kamil Barański, Maciej Hartleb, Magdalena Onyszczuk, Joanna Pilch-Kowalczyk, Sławomira Kyrcz-Krzemień. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregabilityClinics and Research in Hepatology and Gastroenterology 2016; 40(6): 722 doi: 10.1016/j.clinre.2016.03.008
86
Menizibeya Osain Welcome. Gastrointestinal Physiology2018; : 1009 doi: 10.1007/978-3-319-91056-7_15
87
Veronika B. Dubinkina, Alexander V. Tyakht, Vera Y. Odintsova, Konstantin S. Yarygin, Boris A. Kovarsky, Alexander V. Pavlenko, Dmitry S. Ischenko, Anna S. Popenko, Dmitry G. Alexeev, Anastasiya Y. Taraskina, Regina F. Nasyrova, Evgeny M. Krupitsky, Nino V. Shalikiani, Igor G. Bakulin, Petr L. Shcherbakov, Lyubov O. Skorodumova, Andrei K. Larin, Elena S. Kostryukova, Rustam A. Abdulkhakov, Sayar R. Abdulkhakov, Sergey Y. Malanin, Ruzilya K. Ismagilova, Tatiana V. Grigoryeva, Elena N. Ilina, Vadim M. Govorun. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver diseaseMicrobiome 2017; 5(1) doi: 10.1186/s40168-017-0359-2
88
Alexey A. Tinkov, Viktor A. Gritsenko, Margarita G. Skalnaya, Sergey V. Cherkasov, Jan Aaseth, Anatoly V. Skalny. Gut as a target for cadmium toxicityEnvironmental Pollution 2018; 235: 429 doi: 10.1016/j.envpol.2017.12.114
89
Seiichi Ishida. Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studiesDrug Metabolism and Pharmacokinetics 2018; 33(1): 49 doi: 10.1016/j.dmpk.2018.01.003
90
Sang Hyuk Lee, Heon-Ju Kwon, Nam Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Eun Hye Park, Byung Ik Kim. Bowel Wall Thickness, Elasticity, Intestinal Permeability, and Inflammatory Cytokines in Patients with Cirrhosis and AscitesThe Korean Journal of Medicine 2019; 94(6): 511 doi: 10.3904/kjm.2019.94.6.511
91
Michele Pier Luca Guarino, Michele Cicala, Lorenza Putignani, Carola Severi. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiotaWorld Journal of Gastroenterology 2016; 22(45): 9871-9879 doi: 10.3748/wjg.v22.i45.9871
92
Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe, Shin Yoshimoto, Hiroaki Kanda, Yuriko Arai, Yaeko Nakajima-Takagi, Atsushi Iwama, Tomoaki Koga, Yukihiko Sugimoto, Takayuki Ozawa, Masaru Nakamura, Miho Kumagai, Koichi Watashi, Makoto M. Taketo, Tomohiro Aoki, Shuh Narumiya, Masanobu Oshima, Makoto Arita, Eiji Hara, Naoko Ohtani. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor ImmunityCancer Discovery 2017; 7(5): 522 doi: 10.1158/2159-8290.CD-16-0932
93
George V. Tetz, Kelly V. Ruggles, Hua Zhou, Adriana Heguy, Aristotelis Tsirigos, Victor Tetz. Bacteriophages as potential new mammalian pathogensScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07278-6
94
Muzahir Hussain, Muhammad Umair Ijaz, Muhammad Ijaz Ahmad, Iftikhar Ali Khan, Syed Umar Farooq Bukhary, Waqar Khan, Sayed Hussain, Majid Suhail Hashmi, Chunbao Li. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein dietsFood & Function 2020; 11(10): 9168 doi: 10.1039/D0FO02153A
95
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver DiseasesMicroorganisms 2015; 3(4): 759 doi: 10.3390/microorganisms3040759
96
Murali Appukuttan, Senthil Kumar, Kishore Gurumoorthy Subramanya Bharathy, Vijay Kant Pandey, Viniyendra Pamecha. Impact of Functional Hepatic Venous Outflow Obstruction on Perioperative Outcome After Living-Donor Liver TransplantExperimental and Clinical Transplantation 2019; 17(1): 64 doi: 10.6002/ect.2017.0138